SPECIAL NOTICE

We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

InvestoGain Australia

Celebrating 20 Years in Business

Thank you for being part of our development since September 2001. With your ongoing support we look forward to many exciting developments ahead.

SEARCH LISTED COMPANY


Any AUS or NZ company

BROWSE

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH PRIVATE COMPANY


SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

ZELDA THERAPEUTICS LIMITED(ZLD)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

Shareholder links

 

REGISTRY:

Computershare, Level 11, 172 St Georges Terrace, Perth WA 6000

Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 3 9473 2500
RegistryWebsite RegistryEmail

Company details

Address: Level 26 140 St Georges Terrace Perth WA 6000
Tel:  08 6558 0886 Fax: 08 6316 3337

Date first listed: 28/07/2003
Company Secretary: Tim Slate
Sector: Materials Industry Group: XMJ
Activities: Mineral exploration

News & Events

Expand this box to read and print

name changed to Zelira Therapeutics Limited

05/12/2019

The securities of the Company will be reinstated to Official Quotation from the commencement of trading on Tuesday 22 November 2016, following the Company's compliance with Listing Rule 11.1.3 and Chapters 1 and 2 of the ASX Listing Rules.

18/11/2016

The company is pleased to announce that it has successfully raised the maximum allowed under its prospectus offering. A total of 160,000,000 post-consolidation shares will be issued to new investors at 2.5 cents per share raising the full $4,000,000. The funds raised are to continue with pre-clinical R&D activities, fund human clinical trials and expand the management/ advisory team.

15/11/2016

The company issues a second supplementary prospectus intended to be read with the prospectus dated 11 July 2016 and the supplementary prospectus lodged 11 October 2016.

08/11/2016

The company lodges its Quarterly Activities Report.

31/10/2016

The company lodges its Quarterly Cashflow Report.

31/10/2016

The company's meeting will be held at 12.30pm (WST) on 28 November 2016 at CPS Capital Boardroom Level 45, 108 St Georges Terrace Perth WA 6000.

28/10/2016

The company advises that the ASX has granted a waiver from listing rule 14.7 to the extent necessary to permit the Company to issue securities, as approved by shareholders at the general meeting held on 25 July 2016. This is purely a technical issue related to the extended timetable and does not affect any material aspect of the transaction.

26/10/2016

we understand that on or about this date the company consolidated its shares 1 for 5

25/10/2016

The share consolidation has been completed.

12/10/2016

On 11 October 2016, the company lodged a supplementary prospectus with the ASIC which extends the offer period by a minimum of one month. Unfortunately, due to technical issues associated with having the company re-admitted to ASX for quotations the company is required to issue the attached supplementary prospectus and extend the offer period until no earlier than the 11 November 2016.

12/10/2016

name changed from Gleneagle Gold Limited

11/10/2016
OFX Transferring Money Internationally to Free

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...

     


     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

     

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Osagie ImasogieChairman02/12/2019
    Harry KarelisDeputy Chairman17/11/2016
    Richard HopkinsManaging Director01/07/2018
    Lisa GrayDirector02/12/2019
    Jason PetersonDirector17/11/2016
    Oludare OdumosuDirector02/12/2019

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Stewart WasherNon Exec Director17/11/201602/12/2019
    Mara GordonDirector17/11/201602/12/2019
    Leon DaviesNon Exec Director20/04/201117/11/2016
    Ian LoveDirector23/04/201017/11/2016
    Wayne LoxtonDirector23/04/201017/11/2016

    Date of first appointment, title may have changed.